Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell Transplantation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMassachusetts General Hospital

About this trial

Primary PC - or training HCT clinicians to deliver PC domains as part of routine practice - is an alternative model of supportive care. We have developed Sentinel, a primary PC intervention for HCT clinicians and patients. This study will assess Sentinel's feasibility and acceptability.

Eligibility criteria

Qualifiers

Age 18 years or older

Undergoing autologous or allogeneic HCT at MGH

Disqualifiers

Prior receipt of inpatient specialty palliative care on two prior admissions in the past 6 months.

Significant uncontrolled psychiatric disorders (psychotic disorder, bipolar disorder, major depression) or other co-morbid disease (dementia, cognitive impairment), which the primary oncologist believes prohibits informed consent or ability to participate in study procedures

Inability to comprehend English as this is a preliminary/pilot study

Trial design

Treatments tested in this trial

  • Primary palliative care

Treatment groups

40 Participants
are divided into 1 treatment group

Sponsors and collaborators

Massachusetts General Hospital

Lead sponsor

American Society of Transplantation and Cellular Therapy

Collaborator